MA50630A - Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine - Google Patents

Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine

Info

Publication number
MA50630A
MA50630A MA050630A MA50630A MA50630A MA 50630 A MA50630 A MA 50630A MA 050630 A MA050630 A MA 050630A MA 50630 A MA50630 A MA 50630A MA 50630 A MA50630 A MA 50630A
Authority
MA
Morocco
Prior art keywords
pyrrolidine
alpha
preparation
carboxamide derivatives
carboxamide
Prior art date
Application number
MA050630A
Other languages
English (en)
Inventor
Weirong Chen
Vinny Couming
Erwin Irdam
William F Kiesman
Daw-Long A Kwok
Wenli Liang
Tamera L Mack
Suzanne M Opalka
Daniel B Patience
Donald G Walker
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of MA50630A publication Critical patent/MA50630A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
MA050630A 2017-10-05 2018-10-05 Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine MA50630A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762568651P 2017-10-05 2017-10-05

Publications (1)

Publication Number Publication Date
MA50630A true MA50630A (fr) 2021-03-31

Family

ID=65995302

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050630A MA50630A (fr) 2017-10-05 2018-10-05 Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine

Country Status (12)

Country Link
US (2) US11192856B2 (fr)
EP (1) EP3691634A4 (fr)
JP (1) JP2020536870A (fr)
KR (1) KR20200061381A (fr)
CN (1) CN112153968A (fr)
AU (2) AU2018346763A1 (fr)
CA (1) CA3076823A1 (fr)
IL (1) IL273639B2 (fr)
MA (1) MA50630A (fr)
MX (1) MX2020003811A (fr)
SG (2) SG11202002706XA (fr)
WO (1) WO2019071162A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11192856B2 (en) 2017-10-05 2021-12-07 Biogen Inc. Process for preparing alpha-carboxamide pyrrolidine derivatives

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3164597A (en) 1962-12-17 1965-01-05 Geigy Chem Corp 5-carboxylic acid-2-phenyl-pyrrolines, corresponding pyrrolidines and functional derivatives thereof
CH674205A5 (fr) * 1988-05-11 1990-05-15 Lonza Ag
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US6201016B1 (en) 1994-06-27 2001-03-13 Cytomed Incorporated Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
GB9618349D0 (en) 1996-09-03 1996-10-16 Pharmacia Spa N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
IT1290910B1 (it) 1997-02-03 1998-12-14 Sigma Tau Ind Farmaceuti 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
EP2266960B1 (fr) 1999-03-26 2014-01-22 Euro-Celtique S.A. Pyrazoles, imidazoles, oxazoles, thiazoles et pyrroles, substitués d'aryl à titre d'anticonvulsants
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
IT1317049B1 (it) 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
GB0115517D0 (en) 2001-06-25 2001-08-15 Ferring Bv Novel antidiabetic agents
PA8583001A1 (es) 2002-09-20 2004-04-23 Hoffmann La Roche Derivados de 4-pirrolidino-fenil-bencil eter como inhibidores de mao-b
MY142651A (en) 2003-03-18 2010-12-15 Merck Sharp & Dohme Biaryl substituted triazoles as sodium channel blockers
AU2004230854A1 (en) 2003-04-03 2004-10-28 Merck & Co., Inc. Biaryl substituted pyrazoles as sodium channel blockers
CN1805945A (zh) 2003-04-18 2006-07-19 麦克公司 作为钠通道阻滞剂的联芳基取代的噻唑、噁唑和咪唑
WO2005000309A2 (fr) 2003-06-27 2005-01-06 Ionix Pharmaceuticals Limited Composes chimiques
EP1524265A1 (fr) 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Dérivés de prolinamide en tant que bloqueurs du canal sodium et/ou calcium ou inhibiteurs sélectifs de MAO-B
US7253168B2 (en) 2004-04-07 2007-08-07 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
WO2005100334A1 (fr) 2004-04-14 2005-10-27 Pfizer Products Inc. Inhibiteurs de dipeptidyl peptidase-iv
JP2008540443A (ja) 2005-05-04 2008-11-20 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャネルのモジュレーターとして有用なピリミジンおよびピラジン
WO2006119390A1 (fr) 2005-05-04 2006-11-09 Vertex Pharmaceuticals Incorporated Pyridines utiles en tant que modulateurs de canaux ioniques
EP1888549A2 (fr) 2005-05-19 2008-02-20 Vertex Pharmaceuticals, Inc. Biaryles utiles en tant que modulateurs des canaux ioniques
AR058805A1 (es) 2005-09-09 2008-02-27 Smithkline Beecham Corp Derivados biciclicos de piridina utiles como agentes antipsicoticos
US7855218B2 (en) 2005-10-10 2010-12-21 Convergence Pharmaceuticals Limited Compounds
TW200730494A (en) * 2005-10-10 2007-08-16 Glaxo Group Ltd Novel compounds
TW200728258A (en) 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
TW200808788A (en) * 2006-04-19 2008-02-16 Astellas Pharma Inc Azolecarboxamide derivative
JP2007290973A (ja) * 2006-04-21 2007-11-08 Univ Nagoya 亜鉛−マグネシウムアート錯体を含む求核試薬及びそれを使用する求核付加体の製造方法
GB0701365D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
GB0701366D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
US20100105688A1 (en) 2007-01-24 2010-04-29 Glaxo Group Limited Pharmaceutical compositions comprising 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazine or r(-)-2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethyl pyrimidine and an nk1
GB0706630D0 (en) 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds
DK2477964T5 (en) 2009-09-14 2015-05-26 Convergence Pharmaceuticals A process for the preparation of alpha-carboxamide
US20110144081A1 (en) * 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
WO2011155337A1 (fr) 2010-06-11 2011-12-15 シャープ株式会社 Dispositif à cristaux liquides
SI2598479T1 (sl) * 2010-11-11 2015-06-30 Aarti Healthcare Limited Postopek za pripravo ramiprila
WO2016102967A1 (fr) * 2014-12-23 2016-06-30 Convergence Pharmaceuticals Limited Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine
WO2016160574A2 (fr) 2015-03-27 2016-10-06 Scifluor Life Sciences, Inc. Composés d'aryl-et hétéroaryl-pyrrolidine-2-carboxamide
CN106467513A (zh) * 2016-09-30 2017-03-01 陕西科技大学 一种制备Niraparib的合成方法
US11192856B2 (en) 2017-10-05 2021-12-07 Biogen Inc. Process for preparing alpha-carboxamide pyrrolidine derivatives
MX2021012420A (es) 2019-04-10 2022-02-10 Biogen Ma Inc Proceso para preparar derivados de pirrolidina alfa-carboxamida.
EA202192764A1 (ru) 2019-04-10 2022-03-10 Байоджен Инк. Способы получения производных альфа-карбоксамид пирролидина

Also Published As

Publication number Publication date
MX2020003811A (es) 2021-01-15
IL273639B1 (en) 2023-03-01
CA3076823A1 (fr) 2019-04-11
KR20200061381A (ko) 2020-06-02
WO2019071162A2 (fr) 2019-04-11
SG11202002706XA (en) 2020-04-29
IL273639B2 (en) 2023-07-01
SG10202112966SA (en) 2021-12-30
WO2019071162A3 (fr) 2020-03-26
US20200270206A1 (en) 2020-08-27
EP3691634A4 (fr) 2021-03-31
IL273639A (en) 2020-05-31
EP3691634A2 (fr) 2020-08-12
AU2018346763A1 (en) 2020-04-16
JP2020536870A (ja) 2020-12-17
AU2023204011A1 (en) 2023-07-13
US20220356154A1 (en) 2022-11-10
US11192856B2 (en) 2021-12-07
CN112153968A (zh) 2020-12-29

Similar Documents

Publication Publication Date Title
MA49752A (fr) Procédés de préparation de composés de pyrrolidine
MA52665A (fr) Procédé d'amélioration de l'expression de l'hémoglobine foetale
MA51988A (fr) Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale
MA43746A (fr) Dérivés de 2-cyanoisoindoline pour le traitement du cancer
MA49700A (fr) Procédé amélioré pour la préparation de dérivés d'aminopyrimidine
MA45155A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
MA49472A (fr) Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole
MA52906A (fr) Procédé de préparation d'amg 416
MA51629A (fr) Procédés de production, purification et formulation de conjugués anticorps-médicaments
MA45183A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
MA49775A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
MA50169A (fr) Procédé de production d'un électrocatalyseur
MA48626A (fr) Procédé de préparation de (3r,4s)-3-acétamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide
MA55917A (fr) Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie
MA51133A (fr) Dérivés de pyrrole utilisés en tant qu'inhibiteurs d'acc
MA42423A (fr) Procédé de préparation d'un revêtement
MA45768A (fr) Procédé pour la préparation de compositions d'immunoglobulines
MA54396A (fr) Procédé de préparation de n-phénylpyrazole-1-carboxamides
MA53370A (fr) Procédé et intermédiaires pour la préparation de bilastine
MA50517A (fr) Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole
IL276483A (en) A continuous process for the preparation of trazodone
MA47022A (fr) Procédé efficace de préparation de conjugués agent de liaison cellulaire-agent cytotoxique
MA51870A (fr) Procédé pour la préparation de composés coupleurs de médicaments
CY1122172T1 (el) Τροποποιητες θειαζολης των a3 υποδοχεων αδενοσινης
PT3830073T (pt) Processo de preparação monotópica de compostos organoiodados intermediários para síntese de ioversol